Therapy control based on the rate of change of intracardiac impedance

• US 7,953,485 B2
• Filed: 04/17/2008
• Issued: 05/31/2011
• Est. Priority Date: 06/29/2005
• Status: Active Grant

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Pastore, Joseph M., Stahmann, Jeffrey E., Hartley, Jesse W., Salo, Rodney W.
• Primary Examiner(s): Layno; Carl H
• Assistant Examiner(s): Gedeon; Brian T
• Application Number:
  US12/105,219
• Publication Number:
  US 20080249583A1
• Time in Patent Office: 1,139 Days
• Field of Search: 607/9, 607/17, 607/18, 607/116
• US Class Current: 607/17
• CPC Class Codes: A61N 1/30 Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
• CPC Class Codes: A61N 1/36521 the parameter being derived from measurement of an electrical impedance

Abstract

A system comprising a medical device that includes an impedance measurement circuit adapted to be coupled to implantable electrodes to obtain an intracardiac impedance signal between electrodes, a therapy circuit operable to deliver a therapy to a subject, and a controller circuit coupled to the impedance measurement circuit and the therapy circuit. The controller circuit determines a time rate of change of the intracardiac impedance signal and adjusts at least one parameter related to therapy in a manner that alters the rate of change.

Claims

1. A system comprising a medical device including:

an impedance measurement circuit adapted to be communicatively coupled to implantable electrodes to provide an intracardiac impedance signal between electrodes;

a therapy circuit configured to deliver pacing therapy to a right ventricle and a left ventricle of a subject; and

a controller circuit communicatively coupled to the impedance measurement circuit and the therapy circuit, wherein the controller circuit is configured to determine a time rate of change of the intracardiac impedance signal, and to adjust a time delay between pacing of the right ventricle and pacing of the left ventricle in order to controllably increase or maximize a magnitude of the time rate of change in a closed feedback loop manner.

2. The system of claim 1, wherein the controller circuit is configured to adjust the time delay between pacing of the right and left ventricles in order to controllably increase or maximize a magnitude of the negative time rate of change in a closed feedback loop manner.

3. The system of claim 1, wherein the controller circuit is configured to adjust the time delay between pacing of the right and left ventricles in order to controllably increase or maximize both a magnitude of the negative time rate of change and a magnitude of the positive time rate of change in a closed feedback loop manner.

4. The system of claim 1, wherein the impedance measurement circuit is adapted to be communicatively coupled to:

a first set of electrodes adapted for placement to correspond to a first impedance vector at a first site of a heart of a subject; and

a second set of electrodes adapted for placement to correspond to a different second impedance vector at a second site of the heart,

wherein the impedance circuit is configured to provide a first intracardiac impedance signal from the first set of electrodes and a second intracardiac impedance signal from the second set of electrodes, and

wherein the controller circuit is configured to;

determine a time rate of change of the first and second intracardiac impedance signals; and

adjust a time delay between pacing of the right and left ventricles in a closed loop feedback arrangement to controllably increase or maximize a magnitude of the time rate of change of both the first and second intracardiac impedance signals.

5. The system of claim 4, wherein the controller circuit is configured to controllably increase or maximize both a positive and a negative magnitude value of the time rate of change of the first and second intracardiac impedance signals.

6. The system of claim 4, wherein the first set of electrodes is adapted for placement in or near a left ventricle of the heart and the second set of electrodes is adapted for placement in a right ventricle of the heart.

7. The system of claim 4, wherein the first set of electrodes adapted for placement in a right atrium of the heart and the second set of electrodes is adapted for placement in a right ventricle of the heart.

8. The system of claim 4, wherein the controller circuit is configured to give more weight to increasing or maximizing the magnitude of the time rate of change of the first intracardiac impedance signal than to increasing or maximizing the time rate of change of the second intracardiac impedance signal.

9. A system comprising a medical device including:

an impedance measurement circuit adapted to be coupled to implantable electrodes to obtain an intracardiac impedance signal between electrodes;

a therapy circuit configured to deliver pacing therapy to a subject; and

a controller circuit communicatively coupled to the impedance measurement circuit and the therapy circuit, wherein the controller circuit is configured to;

determine a time rate of change of the intracardiac impedance signal;

derive a time duration from a cardiac event to a time of peak wall thickness for a ventricle free wall using the time rate of change of the intracardiac impedance signal; and

adjust a therapy parameter provided to the patient to controllably adjust the time duration in a closed feedback loop manner.

10. The system of claim 9, wherein the cardiac event includes an atrial depolarization.

11. The system of claim 9, wherein the implantable electrodes are adapted for placement in a coronary vein, and wherein controller circuit is configured to determine an occurrence of peak wall thickness of the left ventricle.

12. The system of claim 9, wherein the implantable electrodes are adapted for placement in a left anterior descending artery, and wherein controller circuit is configured to determine an occurrence of peak wall thickness of the left ventricle.

13. The system of claim 9, wherein the therapy circuit is configured to deliver pacing therapy to a right ventricle and a left ventricle of a subject;

and

wherein the controller circuit is configured to adjust a time delay between pacing of the right and left ventricles in order to controllably adjust the time duration.

14. The system of claim 9, wherein the therapy circuit is configured to deliver pacing therapy to an atrium and a left ventricle of a subject;

and

wherein the controller circuit is configured to adjust a time delay between pacing of the atrium and the left ventricle in order to controllably adjust the time duration from the cardiac event to the time of peak wall thickness.

15. A system comprising a medical device including:

an impedance measurement circuit adapted to be communicatively coupled to a first set of electrodes adapted for placement to correspond to a first impedance vector at a first site of a heart of a subject, and a second set of electrodes adapted for placement to correspond to a different second impedance vector at a second site of the heart,

wherein the impedance circuit is configured to provide a first intracardiac impedance signal from the first set of electrodes and a second intracardiac impedance signal from the second set of electrodes;

a therapy circuit configured to deliver pacing therapy to a right ventricle and a left ventricle of a subject; and

a controller circuit communicatively coupled to the impedance measurement circuit and the therapy circuit, wherein the controller circuit is configured to;

derive a time to a peak value of the rate of change of the first intracardiac impedance signal and a time to a peak value of the rate of change of the second intracardiac impedance signal, and adjust a time delay between pacing of the right and left ventricles in a closed loop feedback arrangement to controllably decrease or minimize a difference in the time to peak values.

16. The system of claim 15, wherein the controller circuit is configured to measure the time to peak values relative to a sensed atrial depolarization.

17. The system of claim 15, wherein the controller circuit is configured to determine a peak value using the peak-to-peak value of a time rate change of an intracardiac impedance value.

18. The system of claim 15, wherein the controller circuit is configured to determine a peak value using the baseline-to-peak value of a time rate change of an intracardiac impedance value.

19. The system of claim 15, wherein the first set of implantable electrodes includes an electrode adapted for placement in a right ventricle, and the second set of implantable electrodes include an electrode adapted for placement in a coronary vein.

20. The system of claim 15, wherein the first set of implantable electrodes include an electrode adapted for placement in a right ventricle and the second set of implantable electrodes include an electrode adapted for placement in a left anterior descending artery.